340B Entities Keeping Watch on Bills to Create State Drug Affordability Boards
Nine states are considering legislation to create boards to review prescription drug prices and intervene to lower them if drugs become too expensive or if their prices spike. Although the board’s implications for the 340B program have not been fully fleshed out, Colorado covered entity Denver Health has obtained changes to a bill in that state making it more 340B-friendly.
